Pharmacogenetics of antidepressant drugs: current clinical practice and future directions. - Test2 - elhamkhani - TriplyDB

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.

http://www.wikidata.org/entity/Q37989490

about

Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders Neuroimaging studies of depressive disorders in China since 2000.Influence of Serotonin Transporter Gene Polymorphisms and Adverse Life Events on Depressive Symptoms in the Elderly: A Population-Based Study.Epigenetic Modulation of Mood Disorders.Mechanisms of antidepressant resistance Regulatory perspective on remaining challenges for utilization of pharmacogenomics-guided drug developments.Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment.Coding and noncoding gene expression biomarkers in mood disorders and schizophrenia.The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study.Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in generalized anxiety disorder.Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder.Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder.Serotonin transporter gene: a new polymorphism may affect response to antidepressant treatments in major depressive disorder.

P2860

Q26784904-04EF22AA-6975-47A4-A782-F6389645EBAA Q33984828-D0A70538-4CF6-4D45-8CB9-D1A5DD6C2E82 Q35849512-15DC40F9-B659-4F24-9A07-13CE06050380 Q36737217-FD20B89A-CC11-4BAB-A2E8-862F0F1B0BE1 Q37334088-AAD49B03-C245-4FFE-B336-AD7C3D585E1E Q38074713-49D16A88-B40B-4589-82A1-B5CBC37540F3 Q38154916-48375974-3DE9-4268-B37E-EBA1835CDF03 Q38156156-14386305-BBDA-4EE0-B618-921CE6B026F7 Q38453405-69C733C5-4592-4EDC-8423-3DAF8BE34AC8 Q39211780-0CF32D9B-5384-43E4-B1A9-498C1F8B3A97 Q39422188-47ED7A0B-FE5C-4289-9EE2-1A71F0848505 Q46821332-6A9CAEF5-4FDA-4A10-9165-48B864C5E319 Q48267690-512E5B49-6F9D-40F3-89A8-77DF96626D55

P2860

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.

http://www.wikidata.org/entity/Q37989490

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacogenetics of antidepres ...... ractice and future directions.

@en

Pharmacogenetics of antidepres ...... ractice and future directions.

@nl

type

label

Pharmacogenetics of antidepres ...... ractice and future directions.

@en

Pharmacogenetics of antidepres ...... ractice and future directions.

@nl

prefLabel

Pharmacogenetics of antidepres ...... ractice and future directions.

@en

Pharmacogenetics of antidepres ...... ractice and future directions.

@nl

P1433

Q37989490-F7C6BFE3-58BA-42E7-A969-567EA6A0F571

P1476

Q37989490-5AEFF833-1E9D-4AD2-90DE-0DE27C6F087A

P2093

Q37989490-77C4348F-31EB-4587-90B1-AB5B8A12518D

P2860

Q37989490-017F8A1C-4284-4A8C-8608-D229DE1FFC4A

Q37989490-02C058FB-4194-4A94-9A5F-D49A296F4930

Q37989490-038A5095-F7E9-4812-A0CA-A548B43DA6CB

Q37989490-047F66F2-437D-4A94-BD87-8FE15CE66295

Q37989490-05B72099-C39E-4AF8-8135-9316A14AEDDF

Q37989490-08A883C5-B43B-4064-92D5-8B7A38A153A7

Q37989490-0996D723-9420-45B9-80B1-23E5527B5018

Q37989490-09E41005-E705-4A75-A53E-00BDB9979F4B

Q37989490-0DF8ED08-A2D8-49AD-B7C8-52FD52F779BD

Q37989490-0F248546-195C-41A6-92E2-F2FDA2A27850

P304

Q37989490-D3A791A0-A197-48CB-B80E-A1107A9EB6E2

P31

Q37989490-28154CFD-71D2-4A17-802D-E7923B8236AA

P356

Q37989490-B4CEC261-F265-4570-99CE-D9226453A53F

P433

Q37989490-A4DBDAE9-213F-4FE2-B6B4-1A3EF79E84E0

P478

Q37989490-186F486C-BEBD-4500-B315-C87691F852D0

P50

Q37989490-1FF6B8CC-A881-4203-B68E-AB7F2E8649C3

P577

Q37989490-5B45A4BE-1988-489F-BA2B-FB3C9691FB4A

P698

Q37989490-2B3EBBF7-BADC-4C70-A85A-D0DEF6D097A6

P356

P1433

Pharmacogenomics

P1476

Pharmacogenetics of antidepres ...... ractice and future directions.

@en

P2093

Falk W Lohoff

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

Association of a human G-protein beta3 subunit variant with hypertension

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

Metabolic Issues With Atypical Antipsychotics in Primary Care: Dispelling the Myths

A genomewide association study of citalopram response in major depressive disorder

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression

Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder

Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

P304

441-464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.12.1

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Sneha Narasimhan

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22380000

http://www.w3.org/2001/XMLSchema#string